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Study Design 
General population utility valuation study 
 
Objectives 
This study obtained utility valuations from a Canadian general population perspective for 31 
unique Metastatic Epidural Spinal Cord Compression (MESCC) health states and determined 
the relative importance of MESCC-related consequences on quality-of-life. 
 
Summary of Background Data 
Few prospective studies on the treatment of MESCC have collected quality-adjusted-life-year 
weights (termed “utilities”). Utilities are an important summative measure which distills 
health outcomes to a single number that can assist healthcare providers, patients, and policy 
makers in decision making.   
 
Methods 
We recruited a sample of 1138 adult Canadians using a market research company. Quota 
sampling was used to ensure that the participants were representative of the Canadian 
population in terms of age, gender, and province of residence. Using the validated MESCC 
module for the “Self-administered Online Assessment of Preferences” (SOAP)  tool, 
participants were asked to rate 6 of the 31 MESCC health states, each of which presented 
varying severities of 5 MESCC-related dysfunctions (dependent; non-ambulatory; 
incontinent; pain; other symptoms).   
 
Results 
Participants equally valued all MESCC-related dysfunctions which followed a pattern of 
diminishing marginal disutility (each additional consequence resulted in a smaller 
incremental decrease in utility than the previous). These results demonstrate that the general 
population values physical function equal to other facets of quality-of-life. 
 
Conclusions 
We provide a comprehensive set of ex ante utility estimates for MESCC health states that can 
be used to help inform decision making. This is the first study reporting direct utility 
valuation for a spinal disorder. Our methodology offers a feasible solution for obtaining 
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Key Points: 
 
1. We report a comprehensive set of utility estimates for MESCC health states that can 
be used for decision making, such as allocation of limited resources for specific 
treatments 
2. Regression model building revealed that members of the general population value all 
attributes characterizing MESCC health states equally  
3. Direct utility valuation over the internet is a feasible solution for obtaining quality-of-
life data when generic health status questionnaire data is lacking 
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INTRODUCTION 
The decision to offer a patient with metastatic epidural spinal cord compression (MESCC) 
surgery followed by radiotherapy (S+RT) or radiotherapy alone (RT) is difficult because 
survival, physical function, and complications must be considered jointly. Quality-adjusted-
life-year (QALY) analysis could allow patients and clinicians to determine the relative weight 
of these factors and reach an optimal decision. QALYs are calculated using “utilities,” or 
health-related quality of life weights, which are usually derived from patient responses to 
generic health status questionnaires (e.g. EuroQol-5D, Short Form-6D, or Health Utilities 
Index 3).(1) Unfortunately there is a paucity of quality-of-life data for MESCC as few high-
quality studies compare interventions using generic health status measures.  
 
When generic health status measures are not available, utilities can be derived by direct 
valuation. Direct valuation is the classical approach in which individuals rate hypothetical 
health state descriptions using the time-trade-off or standard gamble procedures.(2) These 
procedures can be used to measure utilities for very specific and uncommon health states.  
Best practices in economic evaluation are to recruit a sample of healthy individuals from the 
general population for direct utility valuation.(3,4)  
 
Based on the work of the European Organisation for Research and Treatment of Cancer 
(EORTC),(5)   our group has developed a comprehensive set of 31 unique MESCC health 
state descriptions.(6) We have also developed an online utility valuation module for MESCC 
using the “Self-administered Online Assessment of Preferences” (SOAP) tool. This module 
was found to be valid, reproducible and responsive in a sample of individuals how have not 
experienced MESCC.(6) 
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The primary objective of this study is to obtain general population utility valuations for the 
31 unique MESCC health states. The secondary objective of this study is to determine the 
relative importance of various aspects to quality-of-life in MESCC. 
 
 MATERIAL AND METHODS 
Subjects 
Recruiting a general population probability sample is a time-intensive and costly undertaking. 
Typically this is done by visiting homes, using random-digit-dialing, and selecting random 
phone numbers. In Canada, with over 80% of Canadians age 16 years and older having 
access to the internet,(7) web recruitment offers a practical alternative to traditional 
strategies. As has been done by several other investigators, we recruited participants from a 
proprietary market research panel (Toluna Group Ltd) for this utility elicitation study for 
MESCC.(8–10)    
 
The market research panel was composed of over 80,000 individuals across Canada recruited 
by the company into a panel of potential survey participants through random-digit-dialing, 
internet banner advertisements, and partnerships with corporations to become panel 
members.(11) Panel members agree to be contacted about new surveys. We did not provide 
an incentive for participating in our study. However, the market research company managing 
the panel does award monthly prizes to panel members based on the number and length of 
surveys completed. Quota sampling was used to ensure that the sample of the market research 
panel represented the general Canadian population in terms of region of residence, gender, 
and age based on the 2016 Canadian Census (Supplemental Table 2.1, 
http://links.lww.com/BRS/B409). The market research company sent panel members an e-
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mail invitation to participate in our study. Interested panel members were redirected to a 
secure website hosting the utility valuation exercise.  
Survey Procedures 
Participants were asked to value six health states in the online SOAP MESSC module. The 
SOAP MESCC module has previously been described.(6) Briefly, the first three pages of the 
module explained the utility valuation task, and provided an overview of MESCC. Following 
this, participants completed the standard gamble health state valuation exercises.(6)  
 
Health states were derived from the EORTC item bank and were presented as a point-form 
description of five dysfunctional attributes: dependent (D), non-ambulatory (N), incontinent 
of urine (I), pain (P). EORTC items are restricted to health-related quality of life, and did not 
specifically consider the morbidity of treatment and adverse events Therefore, we reviewed 
prospective studies on MESCC to identify descriptors of these aspects.(6) To develop a 
manageable decision analytic model, the morbidity of treatment and adverse events were 
grouped as an “other symptoms”(S) attribute. Each attribute was characterized by the 
presence (+) or absence (-) of the dysfunctional attribute. Dependence was described as “you 
need help with eating, dressing, washing yourself or using the toilet. You are dependent on 
others.” Other symptoms were described as “You have one or more of: nausea, vomiting, 
shortness of breath, lack of appetite, diarrhea.” Valuations were obtained using standard 
gamble method.(12)  
 
In this study, “perfect” health is represented by the fully functional health state (D-, N-, I-, P-, 
S-). To eliminate any bias introduced by respondents assuming different life expectancies for 
each scenario, all scenarios were framed as having a certain life expectancy of five years; that 
is, for both the probe health scenario, and perfect health, participants were told their life 
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expectancy would certainly be five years.(13) Five years was the maximum survival reported 
in a randomized controlled trial on treatments for MESCC.(14)  
Participants were asked to value six health states. Two health states formed a “test pair.” 
These pairs shared non-dysfunctional attributes (eg. D-, N+, I-, P-, S- and D-, N+, I-, P- , S+). 
The other four health states were selected at random.   
 
Statistical Analysis 
We deemed participants to have misunderstood the task, or not engaged, if: they provided an 
illogical valuation for the test pair; or provided the same valuation for more than 4 health 
states. Such participants were excluded from the analysis. A sensitivity analysis including all 
participants is provided in Supplemental Text 3, http://links.lww.com/BRS/B409. 
 
Utility values lie between 0 and 1 with 0 representing death and 1 perfect health.  Therefore 
beta regression analysis was chosen to explore the relationship between health attributes and 
utility valuation (Supplemental Text 1, , http://links.lww.com/BRS/B409).(15) Regression 
was performed on the mean ( ) of the beta model. The dispersion parameter was treated as a 
constant.(15) To account for the presence of six observations per participant (indexed by ), 
we incorporated a random intercept term for each participant (ϵ ) in the model for .(16) 
  
The SOAP MESCC module is designed for ex ante (without experience) utility valuation 
from a general population sample. These utilities should reflect population preferences for the 
health states and were used to compute expected (mean) quality-of-life changes in economic 
analysis.   
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Within this context, the objective of the analysis was to estimate mean utilities for the 
population, not predict individual utility valuations. Consequently, goodness-of-fit measures 
such as the R2 statistic or root mean squared (RMSE) are not appropriate because they 
quantify how well the model fits individual observations.(17) To instead quantify the 
performance of the regression model in estimating the mean utility for the 31 health states 
relative to direct estimation of mean utilities, we used the absolute agreement intraclass 
correlation coefficient (ICC). For this ICC calculation, health states were targets and utilities 
were ratings.(18) A two-way model was used because ratings can only be obtained by direct 
estimation or regression estimation.  
 
In an effort to strengthen the generalizability of the regression analysis, we implemented 
internal validation by allocating participants to a test set and validation set in a 1:1 ratio.(19) 
Regression models were fit using the test set, and the optimal model was identified by jointly 
the Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC).(20) The 
optimal regression model was used to compute mean utilities for each health state (regression 
estimation of means). Mean utilities for each health state were then directly estimated using 
the validation set (direct estimation of means). The performance of the optimal regression 
model was quantified using the ICC by comparing mean utilities obtained from the regression 
model to mean utilities obtained by direct estimation.  
 
Four regression models were considered. In Model 1, each dysfunctional attribute was coded 
as a categorical variable. In Model 2, the number of dysfunctional attributes was coded as 
nominal categorical variables. This strategy was used because it avoided assumptions of 
linear or extra-linear effects. Model 3 incorporated all first-order interactions in Model 1. 
Model 4 combined Model 1 and Model 2.  
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Before proceeding with model selection, we graphically checked all four models for 
misspecification of the variance and link function.(21) We attempted to simplify the optimal 
model using standard regression model building procedures.(22) These procedures ultimately 
led us to consider two additional models. In Model 5, the square root of the number 
dysfunctional attributes (num dys) was included as a continuous predictor. In Model 6, the 
natural logarithm of the number dysfunctional attributes (num dys) was included as a 
continuous predictor. The formula for the beta regression linear predictor for each model is 
outlined in Supplemental Text 3, http://links.lww.com/BRS/B409.   
 
Sample Size Calculation 
The sample size for the regression analysis was based on a commonly cited rule-of-thumb 
that linear regression requires 10 to 20 subjects per variable.(23) Our regression models 
considered a total of 21 variables: four numerical variables, five categorical variables, ten 
interaction terms, and two intercepts. Following this rule of thumb, we would require 
15 21 315 subjects. As we planned to split into a test and validation set in a 1:1 ratio, 
we required 630 subjects. However, to ensure at least 2 participants in each quota, 650 
participants were required (Supplemental Table 2.1, http://links.lww.com/BRS/B409). 
 
RESULTS 
1138 panel members logged into the SOAP MESCC module and provided consent. However, 
488 were excluded for not valuing all health states, providing an illogical valuation for the 
test pair, or providing invariant responses (Figure 1). Of the 1029 participants who valued six 
health states, 379 (36.8%) were excluded for not having understood or engaged in the task. 
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The socio-demographic characteristics of 650 included and 488 excluded participants are 
shown in Table 1. There were no statistically or qualitatively significant differences between 
the groups in terms of sex, age, or province of residence.  
Mean valuations for the 31 health states tended to decrease with an increasing number of 
dysfunctions (Table 2). For example, the mean utility valuation for 1, 2, 3, 4, and 5 
dysfunctions was 0.691, 0.581, 0.471, 0.364, and 0.333 respectively (p-value for trend 
<0.0001).   
 
The functional form of each model and example mean utility calculations are provided in 
Supplemental Text 3, http://links.lww.com/BRS/B409. Calibration and agreement parameters 
for all candidate models are provided in Supplemental Table 3.3, 
http://links.lww.com/BRS/B409. The model selection procedure identified the square root of 
the number of dysfunctions to be the optimal predictor of mean utility based on both the AIC 
and BIC criteria (Table 3).  
 
The coefficients for Model 4 are given in Table 4. This model was well calibrated, estimating 
mean utilities in the validation set with a mean absolute error of 0.047 and mean signed 
difference of -0.02  (both of which are less than the MCID of 0.05 for utilities)(Figure 
2).(24,25) There was excellent agreement between mean utilities obtained from this 
regression model and mean utilities obtained by direct estimation with an ICC of 0.936 (95% 
CI: 0.86, 0.97).(26)  
 
Mean and median utility valuations were not sensitive to the inclusion of all participants 
(Supplemental Table 3.6, http://links.lww.com/BRS/B409). 
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Formulas for the linear predictor in the beta regression are provided in Supplemental Table 
3.1, http://links.lww.com/BRS/B409. Formulas for mean utility valuation for a given MESCC 
health state using the fitted models are provided in Supplemental Table 3.5, 
http://links.lww.com/BRS/B409. To illustrate the use of these formulas, we will calculate 
mean utilities for the health state D-, N+, I-, P+, S- using the optimal Model 4. This health 
state is coded as: num dys 2. Therefore using Model 4 the mean utility valuation is 
calculated as: 




In this paper we report directly valued utilities for MESCC health states using the validated 
SOAP MESCC module.(6)  The study sample was representative of the population in all 
English-speaking Canadian provinces. Our findings are valid with 63.2% of participants 
having understood and engaged in the task. This rate is superior to validity rates reported in 
general population direct valuation studies for the EuroQol-5D.(27–30) 
 
The regression model building exercise revealed that members of the general population 
value all dysfunctions characterizing MESCC health states equally. Furthermore, dysfunction 
follows a pattern of diminishing marginal disutility. That is, each additional dysfunction 
effects a smaller incremental change in utility than the previous dysfunction. These results 
demonstrate that from the societal perspective, physical function is valued equal to other 
facets of well-being.  
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It must be recognized that ex post utilities are not equivalent to ex ante utilities obtained from 
patients who have experienced the health states.(31) In part due to adaptation, patients tend to 
provide higher valuations for health states which predominantly affect physical health than 
the general population for the same health state. The ex ante utilities collected in this study 
are highly appropriate for facilitating healthcare decision making and can be used to conduct 
decision analysis and cost-utility analysis for MESCC.(32) 
Although it may seem that applying lower ex ante utilities may infringe on patient autonomy 
and deny care, healthcare system decision making impacts patients with various conditions. If 
the objective of healthcare decision making is to maximize the benefit of all patients, utilities 
across different disease must be comparable in order to set priorities. Rawles argues that ex 
ante utilities can be used ethically if valued under a “veil of ignorance” (33). If we assume 
that the general population providing ex ante utility valuations may eventually develop the 
condition of interest, out of self-interest, they should provide fair valuations. Although ex 
ante utilities are theoretically restricted to system policy decisions, ex ante utilities have 
become the de facto standard for individual patient decisions. Utilities obtained from generic 
health surveys such as the EuroQol-5D, Short Form-6D, and Health Utilities Index 3 are 
actually ex ante valuations.(1) Therefore we have chosen to evaluate ex ante SOAP MESCC 
module to conform with conventions in the literature.  
 
Utility valuations for a single health state were highly variable across participants. This was 
evidenced by wide Inter-quartile ranges. However, since our objective was to measure 
general population ex ante utilities for health policy decision making, the expected values and 
the underlying uncertainty represented by the 95% confidence intervals are pertinent.  
 
Copyright © 2019 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Health policy decisions concern the allocation of scarce resources to health programs with 
superior cost-effectiveness ratios at the expense of those with inferior cost-effectiveness 
ratios.(1) If cost-effectiveness ratios are uncertain, there is a risk that a wrong policy decision 
will be made (ie. funding the program with an inferior cost-effectiveness ratio). Even if the 
risk of a wrong policy decision is large (ie. great uncertainty in cost-effectiveness ratio), from 
both ethical and economic perspective a decision should still be made.(34) From an ethical 
perspective, deferring a decision (ie. not funding any health program under consideration) 
denies care to several groups of patients. From the economic perspective, convincing 
arguments have been given to defend the practise of expected value decision making – i.e. the 
irrelevance of inference with respect to public decision making.(35) For these reasons, 
unbiased estimates of costs and effects are more important than precise estimates.  
 
The results of the regression model building exercise have relevance for clinicians 
counselling MESCC patients regarding treatment. As dysfunctions follow a pattern of 
diminishing marginal disutility, each dysfunction is valued equal to the others – it is the total 
number of dysfunctions that drive quality-of-life. Surgeons should be cognizant that 
ambulation and continence, which are dysfunctions addressed by surgery, are no more 
important than other attributes (pain, other symptoms, and level of independence). 
Furthermore, attempting to reverse a single dysfunction in a patient with high functional 
status will lead to a greater increase in quality-of-life relative to a patient with low functional 
status. 
 
To our knowledge, this is the first study reporting direct utility valuation for a spinal disorder. 
Utilities for spine disease specific instruments such as the NDI, ODI, and SRS-22 have been 
developed using an indirect “cross-walk” protocol.(36–39) Patient responses are collected 
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using both the disease specific instrument and a generic health measure (eg. EuroQol-5D, 
Short Form-6D, and Health Utilities Index 3). Next, a regression model is developed to relate 
the disease specific score to the generic health measure. Then the regression model estimated 
generic health measure score can be used to compute a utility. However, utilities obtained 
from generic health measure scores are actually computed from another regression model 
relating the generic health measure score to directly valued utilities.(1) Our study 
demonstrates that disease specific direct utility valuation is feasible and valid. Investigators 
may consider applying our study protocol and the validated SOAP tool to other disease 
contexts. This approach may eliminate the potential error of the cross-walk approach 
introduced by the need for two regression models. 
 
CONCLUSION 
We provide a comprehensive set of ex ante utility estimates for MESCC health states. The 
utility values derived from this study can be used to help inform population level healthcare 
decision making, such as allocation of limited resources for specific treatments.  The results 
of this study can also help clinicians counsel MESCC patients regarding treatment. 
 
This is the first study reporting direct utility valuation for a spinal disorder.  We demonstrate 
that direct utility valuation over the internet is a feasible solution for obtaining quality-of-life 
data when generic health status questionnaire data is lacking. Investigators may consider 
applying our approach to other disease contexts. 
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Table 1. Baseline characteristics of participants 
  Included 
N = 650 
Excluded 
N = 488  
Sex – no. (%)   
 Female 331 (51)  234 (48) 
 Male 319 (49) 254 (52) 
Age – no. (%)     
 18 – 24 yrs  78 (12) 41 (8) 
 25 – 34 yrs 113 (17) 76 (16) 
 35 – 44 yrs 106 (16) 83 (17) 
 45 – 54 yrs 118 (18) 91 (19) 
 55 – 64 yrs 107 (17) 79 (16) 
 ≥ 65 yrs 128 (20) 118 (24) 
Province – no. 
(%) 
   
 Maritimes 57 (9) 40 (8) 
 Ontario 326 (50) 265 (54) 
 Manitoba 30 (5) 27 (6) 
 Saskatchewan 26 (4) 9 (2) 
 Alberta 98 (15) 65 (13) 
 British 
Columbia 
113 (17) 82 (17) 
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Table 2. Utility valuations for all MESCC health states 
Health State Number of 
Dysfunctions 
N Mean (95% CI) Median (IQR) 
D+N-I-P-S- 1 181 0.676 (0.628, 
0.725) 
0.75 (0.45, 0.95) 
D-N+I-P-S- 1 185 0.717 (0.671, 
0.763) 
0.85 (0.55, 0.95) 
D-N-I+P-S- 1 187 0.681 (0.632, 0.73) 0.85 (0.45, 0.95) 
D-N-I-P+S- 1 182 0.695 (0.647, 
0.743) 
0.85 (0.512, 0.95) 
D-N-I-P-S+ 1 202 0.685 (0.639, 
0.732) 
0.85 (0.462, 0.95) 
D+N+I-P-S- 2 88 0.548 (0.474, 
0.623) 
0.65 (0.225, 0.9) 
D+N-I+P-S- 2 108 0.619 (0.554, 
0.684) 
0.75 (0.4, 0.95) 
D+N-I-P+S- 2 106 0.542 (0.475, 
0.608) 
0.575 (0.25, 0.85) 
D+N-I-P-S+ 2 112 0.6 (0.534, 0.666) 0.7 (0.35, 0.95) 
D-N+I+P-S- 2 88 0.659 (0.589, 
0.728) 
0.75 (0.45, 0.95) 
D-N+I-P+S- 2 107 0.57 (0.505, 0.635) 0.65 (0.325, 
0.875) 
D-N+I-P-S+ 2 105 0.513 (0.44, 0.586) 0.6 (0.1, 0.9) 
D-N-I+P+S- 2 100 0.583 (0.514, 
0.652) 
0.65 (0.35, 0.9) 
D-N-I+P-S+ 2 89 0.601 (0.525, 
0.676) 
0.65 (0.3, 0.95) 
D-N-I-P+S+ 2 113 0.582 (0.514, 0.65) 0.65 (0.25, 0.95) 
D+N+I+P-S- 3 81 0.512 (0.428, 
0.596) 
0.55 (0.1, 0.9) 
D+N+I-P+S- 3 76 0.443 (0.363, 
0.524) 
0.45 (0.1, 0.75) 
D+N+I-P-S+ 3 80 0.492 (0.413, 
0.572) 
0.5 (0.075, 0.75) 
D+N-I+P+S- 3 88 0.445 (0.367, 
0.524) 
0.45 (0, 0.75) 
D+N-I+P-S+ 3 96 0.491 (0.415, 
0.566) 
0.5 (0.1, 0.85) 
D+N-I-P+S+ 3 88 0.479 (0.398, 0.56) 0.6 (0, 0.813) 
D-N+I+P+S- 3 86 0.478 (0.401, 
0.554) 
0.525 (0.1, 0.75) 
D-N+I+P-S+ 3 81 0.407 (0.329, 
0.485) 
0.45 (0, 0.75) 
D-N-I+P+S+ 3 91 0.501 (0.426, 
0.576) 
0.5 (0.15, 0.85) 
D-N+I-P+S+ 3 81 0.457 (0.374, 0.45 (0, 0.8) 
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0.539) 
D+N+I+P-S+ 4 192 0.408 (0.357, 0.46) 0.35 (0, 0.75) 
D+N+I+P+S- 4 199 0.359 (0.308, 0.41) 0.25 (0, 0.65) 
D+N+I-P+S+ 4 191 0.342 (0.292, 
0.391) 
0.25 (0, 0.65) 
D+N-I+P+S+ 4 173 0.357 (0.303, 
0.411) 
0.25 (0, 0.65) 
D-N+I+P+S+ 4 170 0.351 (0.297, 
0.404) 
0.25 (0, 0.65) 
D+N+I+P+S+ 5 174 0.333 (0.281, 
0.384) 
0.2 (0, 0.638) 
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Table 3. Selection parameters for all models 
 Description AIC BIC 
Model 1 Attributes -
2750.242 
-899.148 
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Table 4. Summary of regression analysis using Model 4 
 Variable Coefficient  -value -value   
 
coefficients 
Intercept 1.70580 0.11594 14.71 <0.0001   
 Square root of 
number of 
dysfunctions 
-1.11247 0.07175 -15.51 <0.0001   
 
coefficient 
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Figure 1. Flow of participants 
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Figure 2. Calibration Plot for Model 4 
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